Načítá se...

Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial

SCOPE: Xanthohumol, a prenylflavonoid from hops, has been extensively studied preclinically but has undergone limited research in human subjects. A triple-masked, placebo-controlled phase I clinical trial was conducted to examine the safety and tolerability of xanthohumol. METHODS AND RESULTS: Thirt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Nutr Food Res
Hlavní autoři: Langley, Blake O., Ryan, Jennifer Joan, Hanes, Douglas, Phipps, John, Stack, Emily, Metz, Thomas O., Stevens, J. Frederik, Bradley, Ryan
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8221389/
https://ncbi.nlm.nih.gov/pubmed/33629812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mnfr.202001170
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!